Nifty

:

23850.90

Sensex

:

78782.24

-453.45 (-1.87%)
-606.82 (-0.76%)

Login

Nifty
Sensex

:
:

23850.90
78782.24

-453.45 (-1.87%)
-606.82 (-0.76%)

Medico Remedies Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 540937 | NSE: MEDICO

Watchlist

NSE BSE

39.50

05-Jul-2024

Open
High
Low
Previous Close

40.85
40.90
39.20
40.02

Volume
Traded Value (lacs)
52 Week High
52 Week Low

64160
25.58
92.95
34.80

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

477.16
55.81
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

483.73
N/A
8.84

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.01
10.33
6.19

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.11
35.37
11.99

PAT CAGR (%)

10 Years
5 Years
3 Years

26.50
38.44
19.90

P:E (Median)

8 Years
5 Years
3 Years

-
58.94
73.76

P:BV (Average)

8 Years
5 Years
3 Years

-
9.09
10.12

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
35.80
39.31

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 30.80 31.47 -2.13% 41.32 27.99 47.62% 29.77 38.85 -23.37% 42.36 40.46 4.70%
Expenses 27.99 29.01 -3.52% 36.68 24.83 47.72% 27.04 35.46 -23.75% 39.28 37.31 5.28%
EBITDA 2.81 2.46 14.23% 4.65 3.16 47.15% 2.73 3.39 -19.47% 3.08 3.15 -2.22%
EBIDTM 9.12% 7.80% 11.24% 11.30% 9.18% 8.72% 7.26% 7.78%
Other Income 0.29 0.31 -6.45% 0.58 0.04 1,350.00% 0.27 0.86 -68.60% 0.96 1.55 -38.06%
Interest 0.18 0.17 5.88% 0.25 0.21 19.05% 0.22 0.20 10.00% 0.18 0.17 5.88%
Depreciation 0.75 0.71 5.63% 0.74 0.73 1.37% 0.72 0.74 -2.70% 0.71 0.66 7.58%
PBT 2.17 1.88 15.43% 4.25 2.27 87.22% 2.06 3.31 -37.76% 3.14 3.86 -18.65%
Tax 0.60 0.56 7.14% 1.15 0.51 125.49% 0.62 1.07 -42.06% 0.72 0.99 -27.27%
PAT 1.58 1.32 19.70% 3.10 1.77 75.14% 1.44 2.25 -36.00% 2.43 2.87 -15.33%
PATM 5.13% 4.20% 7.50% 6.31% 4.85% 5.79% 5.73% 7.09%
EPS 0.19 0.16 18.75% 0.37 0.21 76.19% 0.17 0.27 -37.04% 0.29 0.35 -17.14%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 144.25 144.92 140.44 121.02 122.39 88.64 97.69 61.02 54.42 66.68 50.99 Net Sales Growth 3.95% 3.19% 16.05% -1.12% 38.08% -9.26% 60.10% 12.13% -18.39% 30.77% Cost Of Goods Sold 108.08 95.70 88.33 70.74 79.37 57.38 67.79 33.50 29.35 53.00 39.24 Gross Profit 36.17 49.22 52.11 50.29 43.02 31.25 29.90 27.52 25.07 13.68 11.76 GP Margin 25.07% 33.96% 37.10% 41.56% 35.15% 35.25% 30.61% 45.10% 46.07% 20.52% 23.06% Total Expenditure 130.99 132.01 130.96 113.69 117.15 85.80 94.93 57.54 50.41 63.03 48.09 Power & Fuel Cost - 2.55 2.47 2.29 1.91 1.83 1.73 1.42 1.05 0.00 0.00 % Of Sales - 1.76% 1.76% 1.89% 1.56% 2.06% 1.77% 2.33% 1.93% 0% 0% Employee Cost - 5.92 5.68 5.41 4.50 3.83 3.32 3.89 4.42 4.25 3.41 % Of Sales - 4.09% 4.04% 4.47% 3.68% 4.32% 3.40% 6.37% 8.12% 6.37% 6.69% Manufacturing Exp. - 20.88 22.36 23.00 18.02 15.00 16.03 13.73 11.00 0.00 0.00 % Of Sales - 14.41% 15.92% 19.01% 14.72% 16.92% 16.41% 22.50% 20.21% 0% 0% General & Admin Exp. - 2.07 1.97 2.12 2.38 2.20 1.49 1.33 1.49 5.77 5.44 % Of Sales - 1.43% 1.40% 1.75% 1.94% 2.48% 1.53% 2.18% 2.74% 8.65% 10.67% Selling & Distn. Exp. - 3.93 9.60 9.03 8.30 4.80 3.86 2.82 2.69 0.00 0.00 % Of Sales - 2.71% 6.84% 7.46% 6.78% 5.42% 3.95% 4.62% 4.94% 0% 0% Miscellaneous Exp. - 0.97 0.54 1.10 2.67 0.75 0.71 0.84 0.41 0.00 0.00 % Of Sales - 0.67% 0.38% 0.91% 2.18% 0.85% 0.73% 1.38% 0.75% 0% 0% EBITDA 13.27 12.91 9.48 7.33 5.24 2.84 2.76 3.48 4.01 3.65 2.90 EBITDA Margin 9.20% 8.91% 6.75% 6.06% 4.28% 3.20% 2.83% 5.70% 7.37% 5.47% 5.69% Other Income 2.10 2.13 4.09 2.03 1.03 2.10 1.90 0.91 0.36 0.24 0.11 Interest 0.83 0.82 0.75 0.66 0.92 1.06 0.98 1.52 1.33 0.85 0.82 Depreciation 2.92 2.88 2.72 2.22 1.65 1.66 1.51 1.00 1.05 1.18 1.09 PBT 11.62 11.33 10.10 6.48 3.70 2.22 2.18 1.87 1.99 1.87 1.10 Tax 3.09 3.04 2.86 1.67 1.11 0.58 0.60 0.65 0.06 0.74 0.31 Tax Rate 26.59% 26.83% 28.32% 25.77% 30.00% 26.13% 27.52% 34.76% 3.55% 39.57% 28.18% PAT 8.55 8.29 7.24 4.81 2.59 1.63 1.57 1.22 1.63 1.13 0.79 PAT before Minority Interest 8.55 8.29 7.24 4.81 2.59 1.63 1.57 1.22 1.63 1.13 0.79 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.93% 5.72% 5.16% 3.97% 2.12% 1.84% 1.61% 2.00% 3.00% 1.69% 1.55% PAT Growth 4.14% 14.50% 50.52% 85.71% 58.90% 3.82% 28.69% -25.15% 44.25% 43.04% EPS 1.03 1.00 0.87 0.58 0.31 0.20 0.19 0.15 0.20 0.14 0.10

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 52.37 43.84 36.57 32.46 29.87 28.24 26.67 16.37 14.74 13.61 Share Capital 16.60 16.60 16.60 4.15 4.15 4.15 4.15 3.20 1.60 1.60 Total Reserves 35.77 27.25 19.98 28.31 25.72 24.09 22.52 13.17 13.14 12.01 Non-Current Liabilities 1.26 2.08 2.50 5.21 4.92 2.63 2.55 10.93 4.39 0.63 Secured Loans 0.00 0.00 0.65 4.70 4.46 2.13 1.94 2.62 0.00 0.00 Unsecured Loans 0.25 0.25 0.25 0.25 0.25 0.25 0.25 8.22 3.70 0.00 Long Term Provisions 0.00 0.06 0.05 0.10 0.00 0.00 0.09 0.07 0.00 0.00 Current Liabilities 44.58 43.15 39.57 37.95 40.48 45.45 30.17 21.11 26.41 21.51 Trade Payables 31.51 30.99 27.10 25.35 26.40 32.52 17.52 11.88 15.36 13.15 Other Current Liabilities 3.43 1.79 1.57 4.32 6.95 2.66 2.97 1.23 0.61 0.22 Short Term Borrowings 6.50 7.85 9.06 8.11 7.12 10.27 9.69 7.90 10.10 7.89 Short Term Provisions 3.13 2.53 1.84 0.17 0.01 0.00 0.00 0.09 0.34 0.25 Total Liabilities 98.21 89.07 78.64 75.62 75.27 76.32 59.39 48.41 45.54 35.75 Net Block 21.49 21.83 18.03 15.31 12.55 12.27 6.63 6.84 7.09 7.97 Gross Block 41.34 38.80 32.39 28.89 24.36 22.43 15.37 14.57 13.77 13.47 Accumulated Depreciation 19.85 16.97 14.36 13.58 11.82 10.17 8.74 7.73 6.68 5.50 Non Current Assets 22.43 22.91 19.65 17.14 18.63 17.13 13.69 10.25 8.72 9.51 Capital Work in Progress 0.00 0.07 0.00 0.00 2.28 0.90 4.37 2.76 0.00 0.00 Non Current Investment 0.20 0.00 0.00 0.11 0.15 0.15 0.24 0.29 0.51 1.04 Long Term Loans & Adv. 0.56 0.85 1.54 1.72 3.59 3.77 2.46 0.36 1.10 0.50 Other Non Current Assets 0.18 0.16 0.07 0.00 0.06 0.05 0.00 0.00 0.01 0.00 Current Assets 75.78 66.17 59.01 58.48 56.64 59.18 45.69 38.16 36.83 26.23 Current Investments 1.36 1.27 0.00 1.06 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 16.34 19.70 18.11 14.55 18.26 16.07 14.91 10.14 9.17 8.17 Sundry Debtors 49.63 36.09 30.39 27.42 23.89 29.07 17.01 18.12 19.54 7.37 Cash & Bank 0.18 0.91 2.34 2.83 1.42 0.61 0.81 0.71 0.66 1.82 Other Current Assets 8.27 0.29 0.38 0.52 13.07 13.43 12.96 9.19 7.46 8.87 Short Term Loans & Adv. 7.84 7.91 7.78 12.10 12.67 12.99 12.60 8.88 7.21 8.48 Net Current Assets 31.20 23.02 19.43 20.53 16.16 13.74 15.52 17.05 10.42 4.73 Total Assets 98.21 89.08 78.66 75.62 75.27 76.31 59.38 48.41 45.55 35.74

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 2.44 8.17 5.86 -11.31 0.97 4.94 5.10 -3.22 -3.73 -0.32 PBT 11.33 10.10 6.48 3.68 2.22 2.18 1.87 1.69 1.87 1.10 Adjustment 3.53 2.71 2.52 2.57 2.14 1.86 2.15 2.46 1.94 1.83 Changes in Working Capital -9.26 -2.15 -1.34 -16.63 -2.81 1.49 1.64 -6.56 -6.96 -2.87 Cash after chg. in Working capital 5.60 10.66 7.66 -10.38 1.54 5.53 5.66 -2.42 -3.15 0.06 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.17 -2.50 -1.79 -0.93 -0.54 -0.55 -0.55 -0.49 -0.58 -0.38 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 -0.03 -0.04 -0.02 -0.32 0.00 0.00 Cash From Investing Activity -2.68 -6.60 -1.76 -16.96 -3.08 -4.43 -4.98 -2.81 0.32 -2.15 Net Fixed Assets -2.47 -6.48 -3.50 -2.25 -3.31 -3.59 -2.41 -3.56 -0.30 -1.62 Net Investments -0.29 -1.27 1.17 -1.02 0.00 0.09 0.05 0.22 0.53 -0.71 Others 0.08 1.15 0.57 -13.69 0.23 -0.93 -2.62 0.53 0.09 0.18 Cash from Financing Activity -0.49 -1.82 -5.77 18.28 2.60 -0.55 -0.62 5.80 2.25 2.95 Net Cash Inflow / Outflow -0.73 -0.25 -1.67 -9.99 0.48 -0.04 -0.50 -0.23 -1.17 0.48 Opening Cash & Equivalents 0.91 1.17 2.83 0.00 0.16 0.21 0.71 0.66 1.82 1.34 Closing Cash & Equivalent 0.18 0.91 1.17 -9.99 0.65 0.16 0.21 0.43 0.66 1.82

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 6.31 5.28 4.41 19.55 18.00 68.05 64.27 51.16 92.15 85.09 ROA 8.85% 8.63% 6.24% 3.43% 2.15% 2.31% 2.26% 3.47% 2.78% 2.36% ROE 17.23% 18.01% 13.94% 8.31% 5.61% 5.72% 5.67% 10.47% 7.97% 7.14% ROCE 21.90% 21.88% 15.09% 10.13% 7.66% 7.79% 9.05% 9.39% 10.86% 10.01% Fixed Asset Turnover 3.62 3.95 3.95 4.60 3.79 5.17 4.13 4.04 4.90 4.03 Receivable days 107.96 86.40 87.18 76.51 109.06 86.09 103.77 120.17 73.64 47.94 Inventory Days 45.38 49.13 49.25 48.92 70.69 57.88 74.02 61.63 47.46 56.52 Payable days 119.19 120.01 135.32 119.00 187.40 94.07 94.52 101.11 88.47 110.83 Cash Conversion Cycle 34.15 15.53 1.11 6.44 -7.66 49.90 83.26 80.69 32.63 -6.38 Total Debt/Equity 0.13 0.18 0.29 0.46 0.46 0.48 0.47 1.18 0.94 0.58 Interest Cover 14.76 14.52 10.79 5.02 3.09 3.22 2.23 2.27 3.21 2.34

Top Investors:

vijaygopal parasram atal

sanjay narendra bansal

Annual Reports:

News Update:

Medico Remedies - Quarterly Results
12th Aug 2024, 17:18 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback